Hemogenyx Pharmaceuticals (LSE:HEMO) FFO


LSE:HEMO Hemogenyx Pharmaceuticals PLC LSE:HEMO
31 GF Score
Price £7.54
! 2 Warning Signs
View Full Analysis

What is Hemogenyx Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

LSE:HEMO
31GF Score
Hemogenyx Pharmaceuticals PLC LSE:HEMO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemogenyx Pharmaceuticals Business Description

Address 6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments. The Group has one reportable segment, the discovery, development, and commercialisation of treatments relating to blood and immune system disorders and viral infections, and administrative functions in the United Kingdom. It has its presence in United Kingdom; and United States.
31GF Score

Get the complete analysis for LSE:HEMO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£7.54
Price